Skip to main content

AGIO Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Agios Pharmaceuticals Inc. News

Agios Soars on Plan to Sell Cancer Drugs, Return $1.2B to Holders

Drugmaker Agios soared on a plan to sell an oncology portfolio to Servier for up to $2 billion and return $1.2 billion to shareholders.

Celgene, Agios Update Blood Cancer Drug Study Results in ASCO '17 Abstract

The new enasidenib data -- improved tumor response rate but shorter duration -- were made public on Wednesday night in a research abstract.

4 Health Care Charts Signaling Buys: Pfizer, Amgen Included

Obamacare? Trumpcare? These stocks don't care.

These 4 Healthcare Charts Are Signaling Buys

Here's a rundown of four technical setups that are showing solid trading potential.

Biotechs Among 5 Stocks Setting Up for Major Breakouts

Here's how to rake in the profits off some potential big breakouts.

Breaking News

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.